AWM Investment Company Inc. cut its stake in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 19.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 360,147 shares of the medical device company's stock after selling 89,309 shares during the period. AWM Investment Company Inc. owned about 0.94% of Orthofix Medical worth $6,288,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of OFIX. Lazard Asset Management LLC purchased a new position in shares of Orthofix Medical in the 4th quarter valued at $45,000. R Squared Ltd purchased a new position in Orthofix Medical during the fourth quarter worth approximately $50,000. KLP Kapitalforvaltning AS acquired a new stake in Orthofix Medical in the 4th quarter worth about $112,000. Tower Research Capital LLC TRC grew its holdings in shares of Orthofix Medical by 120.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 8,458 shares of the medical device company's stock worth $148,000 after buying an additional 4,627 shares in the last quarter. Finally, State of Wyoming boosted its holdings in shares of Orthofix Medical by 206.8% during the 4th quarter. State of Wyoming now owns 9,432 shares of the medical device company's stock worth $165,000 after purchasing an additional 6,358 shares during the last quarter. 89.76% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the stock. Roth Mkm restated a "buy" rating and set a $22.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. Canaccord Genuity Group restated a "buy" rating and issued a $24.00 target price on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, Wall Street Zen cut shares of Orthofix Medical from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th.
View Our Latest Report on OFIX
Orthofix Medical Price Performance
Shares of Orthofix Medical stock traded down $0.13 on Monday, hitting $11.10. The company's stock had a trading volume of 572,966 shares, compared to its average volume of 267,576. The company has a market capitalization of $433.14 million, a P/E ratio of -3.55 and a beta of 0.87. Orthofix Medical Inc. has a 52-week low of $10.50 and a 52-week high of $20.73. The firm has a fifty day moving average price of $13.89 and a 200-day moving average price of $16.57. The company has a quick ratio of 1.11, a current ratio of 2.39 and a debt-to-equity ratio of 0.25.
Insiders Place Their Bets
In other news, CEO Massimo Calafiore bought 10,000 shares of the firm's stock in a transaction dated Friday, May 9th. The stock was acquired at an average price of $12.54 per share, for a total transaction of $125,400.00. Following the acquisition, the chief executive officer now owns 234,603 shares of the company's stock, valued at $2,941,921.62. This trade represents a 4.45% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, major shareholder Engine Capital Management, Lp acquired 100,000 shares of the firm's stock in a transaction on Wednesday, May 7th. The shares were acquired at an average price of $12.31 per share, with a total value of $1,231,000.00. Following the completion of the purchase, the insider now owns 3,544,807 shares of the company's stock, valued at $43,636,574.17. This trade represents a 2.90% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 8,475 shares of company stock worth $128,065. Insiders own 1.30% of the company's stock.
Orthofix Medical Profile
(
Free Report)
Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.
Featured Articles
Before you consider Orthofix Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orthofix Medical wasn't on the list.
While Orthofix Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
